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Abstract
Background: During development neural crest derived Schwann Cell (SC) precursors migrate to nerve trunks and
populate nascent nerves. Axonal ensheathment by SC is a prerequisite for normal nerve function and the integrity
of myelinated as well as nonmyelinated axons. To provide adequate support functions, SC colonize entire nerves.
One important prerequisite for this is their migration into distal axonal regions.
Results: Here, we studied the role of Glial cell line derived neurotrophic factor (GDNF), a TGF-beta related growth
factor, for SC migration. To this end we used a superior cervical ganglion (SCG) explant-SC migration assay, GDNF
null mutant mouse embryos and a chemical inhibitor for GDNF signaling in combination with time-lapse imaging.
We found that GDNF signaling is dispensable for SC migration along murine embryonic sympathetic axons.
Furthermore, in vivo analyzes revealed that SC migration along the sciatic nerve is also not dependent on GDNF.
Conclusions: In contrast to previous in vitro findings in the sciatic nerve and a SC precursor cell line, our results
clearly indicate that GDNF is dispensable for embryonic SC migration. This is demonstrated for the sympathetic
nervous system and also for the sciatic nerve in mouse.
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Background
Schwann cells (SC), the main glial cell type of the per-
ipheral nervous system [1], are crucial for normal nerve
function and long-term integrity of peripheral nerves
[2,3]. Since SC provide support functions for myelinated
as well as nonmyelinated axons, they populate not only
heavily myelinated nerves (e.g. the sciatic nerve) but also
largely nonmyelinated nerves (e.g. sympathetic nerves).
During development, appropriate numbers of axons and
SC are matched by tightly regulated proliferation as well
as apoptosis [4-7]. SC migrate from nerve trunks along
developing axons to distal nerve regions. Several signal-
ing molecules have been shown to regulate SC migra-
tion. The neuronal growth factor Neuregulin (NRG) 1,
acting through ErbB2/ErbB3 tyrosine kinase receptors
[8], stimulates SC motility, as demonstrated in primary
rat SC culture [9,10] or with an immortalized SC
precursor cell line [11,12]. Studies in zebrafish revealed
an essential role of NRG1 type III, ErbB2 and ErbB3 for
SC migration in vivo [13,14] and we have recently shown
that NRG1 type III/ ErbB signaling, via regulation of
apoptosis in proximal axonal regions, is essential for SC
colonization of distal sympathetic axons [7]. In addition
to NRG1, also Glial Cell-line-Derived Growth Factor
(GDNF), a TGF- beta related growth factor, has been
suggested to control SC migration. When expressed in a
layer of fibroblasts, GDNF promotes SC emigration from
sciatic nerve sections. This activity depends on a non-
canonical, Ret kinase independent [15] signaling pathway
in which the neural cell adhesion molecule (NCAM) is
employed in combination with the ligand binding GDNF
family receptor alpha 1 (GFRa1) [16]. A stimulatory
effect of GDNF on SC migration was also observed in
several in vitro migration assays using an immortalized
SC precursor cell line suggesting that GDNF (and NRG1)
serve as chemotactic and chemokinetic molecules during
peripheral nerve development [11]. Here, we addressed
whether endogenous GDNF plays a role for SC migration
along sympathetic nerves of mouse embryos. We took
advantage of a SC migration assay using SCG explants
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[17] and time lapse imaging, which allows to study SC
migration along outgrowing axons [7]. Unexpectedly, we
found that SC migrate normally along sympathetic axons
in the absence of GDNF signaling. Furthermore, in vivo
analyzes of late embryonic sciatic nerves indicated that
SC migration is not dependent on GDNF there.
Methods
Ethics statement
Animal work was carried out in agreement with the local
ethical committees. The University of Heidelberg/ Regier-
ungspräsidium Karlsruhe Referat 35 has approved this
study (ID: T-07/10 and T-59/08)."
Mice and tissue preparation
Time pregnancy matings of NMRI and GDNF KO mice
[18] were performed overnight and the day of the vagi-
nal plug was considered as day 0.5. Additional NMRI
mice, obtained from Charles River, were mated during
daytime. At embryonic day 16 (E16) to 18.5, mothers
were sacrificed by cervical dislocation and the embryos
were harvested by cesarean section. GDNF (Gdnftm1Lmgd)
mice were maintained by breeding to C57/Bl6 mice
and intercrosses.
SC migration assay, pharmacological treatment and
quantification
The assay used to analyze SC migration was recently
described [7]. Briefly, superior cervical ganglia (SCGs)
were dissected from mouse embryos at embryonic day
15.5- 18.5 (E15.5 - E18.5). After washing in dPBS SCGs
were put on a three dimensional matrix of collagen.
Collagen was prepared from rat-tails and the matrix was
assembled according to the protocol of T. Ebendal [19].
SCGs were treated with Nerve Growth Factor (NGF,
R&D or Roche, 30 ng/ml) to facilitate optimal axonal
development and allow SC migration along elongating
axons (Figure 1). PP2 [20] a compound inhibitor for
SRC-kinases and Ret kinase was used at a concentration
(5.3 μM, stock concentration 53 mM in DMSO). PP2
was either added at day in vitro (DIV) 0 or at DIV3. In
the latter case the assay was stopped at DIV4. Analyzes
of SC proliferation were performed by measuring the
pHH3/ DAPI ratio in sampled areas of 11 control and
10 PP2 treated explants. For analyzes of SC migration,
distances from the explant to leading SCs of 13 control
and 12 PP2 treated explanted ganglia were measured.
When indicated Aphidicolin (Serva, 10 μg/μl stock in
DMSO, working concentration 2 μg/ml) was added to
the cultures.
Western Blot for GDNF
Rat-tail collagen samples at different dilutions, pro-
teins from rat adrenal gland, rat cerebrum, PC12 cells
and recombinant murine GDNF (Peprotech, Hamburg,
Germany) were loaded on a 13% SDS-acrylamide gel
for electrophoresis. Proteins were transferred onto a
PVDF membrane (Immobilon, Millipore, Schwalbach,
Germany) using wet-blotting technique. After transfer,
membranes were washed with TBST and blocked with
10% dry milk (Roth, Karlsruhe, Germany) in TBST for
2 h at room temperature. For detection of GDNF, mem-
branes were incubated with primary anti-GDNF antibody
(against human and rat GDNF, R&D Systems, Germany)
at 4°C overnight. The primary antibody treatment was
followed by treatment with HRP-conjugated goat anti-
rabbit antibody (1:10,000, Cell Signaling Technologies)
for 1 h at 4°C. Gapdh was used as a loading control for po-
sitive controls from rat tissue samples. Labelled proteins
were detected by using Western LightningW Plus–ECL,
Enhanced Chemiluminescence Substrate (Perkin-Elmer,
Germany). All blots were captured with Amersham
HyperfilmTM ECL (GE Healthcare).
Immunohistochemistry and statistical analyses
Immunohistochemical stainings for S100 (Sigma, mouse,
monoclonal, 1:10-50) phospho-Histone H3 (pHH3,
Milipore, rabbit polyclonal, 1: 400) Thyrosine Hydroxy-
lase (TH, Chemicon, rabbit, polyclonal, 1:1000, Chemi-
con mouse, 1:400) and nuclear counterstaining with
DAPI (1:10000) were performed according to standard
protocols. Briefly, explant containing collagen gels were
fixed with 4% PFA at the end of an experiment and
directly processed for whole mount immunohisto-
chemistry. Tissue was blocked in PBS containing 10%
normal donkey serum and 2% Triton x 100 for 2 hours
with consecutive antibody incubation in blocking solu-
tion over night. The next day, after washing, the tissue
was incubated with labeled secondary antibodies
(donkey anti rabbit/ donkey anti mouse/Alexa488/ CY3).
Explants used for whole mount immunohistochemistry
were dried on microscope slides, for best analyses in
two dimensions and mounted in aqueous mounting
medium (Mowiol). Images were taken by conventional
fluorescence and non-fluorescence microscopy with
Olympus and Leica microscopes respectively. Measure-
ments were performed via the software imageJ (NIH).
For statistical analyzes of quantitative data Graphpad
Prism software was used.
Time lapse imaging
Where stated, time-lapse recordings were performed in
near live time temporal resolution. The recorded frame
rate is 10 minutes for S3 and S4 and 30 minutes for S1,
S2, S5 and S6. The scale bars represent 100 μm. For time
lapse recordings a conventional inverse Microscope
Setups (Leica and Nikon) connected to an incubation
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chamber and a heating unit was used to facilitate humid
conditions with 37C° and 5% of CO2.
Semi-thin sections
Sciatic nerves were dissected from fixed E18.5 mouse
embryos. After postfixation the nerves were processed
and embedded in Epon (EM-TP, Leica). Sectioning was
performed with an ultramicrotom (Leica) and sections
were stained with methylenblue/azurII.
Results
Early blockade of Src and Ret kinases disrupts axonal SC
colonization
Binding of GDNF to its GPI anchored receptor GFRa1, can
induce two distinct signaling pathways. The first described
was signaling via recruitment of Ret tyrosine kinases to
the GDNF/ GFRa1 complex. The more recently observed
pathway works via interaction with the neural cell adhesion
molecule (NCAM). The latter way was described to utilize
fyn a src-related kinase in the signaling cascade [15,16].
Blockade of both pathways, by inhibition of src and Ret
kinases with PP2, at day in vitro (DIV) 0 (treatment
scheme Figure 2A) disrupted SC colonization of SCG
axons (Figure 2C). This can additionally be appreciated in
time-lapse recordings (Additional file 1: Movies S1 and
Additional file 2: S2). While SC migrate along axons in
control explants (Figure 2B, Additional file 1: Movie S1),
migrating SC were virtually absent when explants were
treated with PP2 (Additional file 1: Movie S2).
Late blockade of Src and Ret kinases reduces SC proliferation
To directly address the effect of Ret and src kinase sig-
naling inhibition on SC migration, PP2 was administered
at DIV3 (treatment scheme Figure 3A), when numerous
axon-associated SC already migrated away from the
NGF treated explants. Migration distances from the
SCG explant to the leading SC were measured at DIV4
(Figure 1D). Unexpectedly, under these conditions only
a small (not significant) reduction in SC migration
distances was observed (Figure 3F). Additional time-
lapse recordings (Additional file 3: Movie S3 ctr and
Additional file 4: Movie S4 PP2) show migrating SC in
the PP2 treated sample similar to the control. These
findings argue against a direct role of Src or Ret kinases
in SC migration along sympathetic axons. However, we
want to note that SC motility seems by trend slightly
reduced after PP2 treatment (Additional file 3: Movie
S3/Additional file 4: Movie S4).
If a SCG explant is solely treated with NGF, large
numbers of SC migrate away from the explant to distal
axonal regions (Additional file 1: Movie S1). We specu-
late that SC precursors must massively proliferate before
the onset of migration. To test whether PP2 affects SC
proliferation we determined pHH3/DAPI ratios of SCG
explants treated with PP2 at DIV3. We observed a reduc-
tion in the number of proliferating SC in PP2 treated
samples compared to controls (Figure 3G). In addition
more fragmented SC nuclei were visible after PP2 treat-
ment, in line with increased SC apoptosis (Figure 3D/E).
Figure 1 Scheme showing the experimental setup of the SCG SC migration assay. SCGs were explanted and put onto/in a collagen-gel.
NGF treatment facilitates axonal growth (B) into the collagen matrix. Axons elongate further over the time (C) and SCs (blue) can be appreciated
migrating along the axons from the SCG explant to the periphery as depicted in the close up (D). At the endpoint of analyses the gel was shrunk
to two dimensions to enable the measurement from the border of the SCG explant to the leading SC (red dotted lines in D).
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This suggests that the failure in colonization of sym-
pathetic axons after PP2 treatment at DIV0 might result
from reduced numbers of premigratory SC in the explants.
Blocking SC proliferation at DIV0 recapitulates early
PP2 phenotype
To test our hypothesis that reduced SC proliferation dis-
rupts axonal SC colonization, we blocked SC prolifera-
tion at DIV0 by treatment with aphidicolin, a DNA
polymerase inhibitor [7], (treatment scheme Figure 4A)
and analyzed SC migration. In controls as well as after
aphidicolin treatment axonal growth was observed
(Figure 4B/F/D/H). However, hardly any SC were detect-
able that migrated out of the explant along the axons
after SC proliferation was inhibited (Figure 4G/I). Only
occasional cells can be observed along the elongated
axons (Figure 4, arrows). In addition to blocked prolif-
eration, we also noticed nuclear debris (Figure 4, arrow-
heads) in controls and aphidicolin treated explants. Cells
either died along axons or the detritus was pushed away
from the explants during axonal growth. The almost
total lack of SC after blockade of SC proliferation at
DIV0 suggests that a certain amount of SC is required
to initiate migration.
GDNF is dispensable for SC migration along
sympathetic axons
Next we directly addressed the role of GDNF for SC mi-
gration along sympathetic axons by using SCG explants
from GDNF knock out (KO) mice [18]. To rule out pos-
sible GDNF-contamination of the 3D collagen (rat-tail)
matrix based migration assay we performed a Western
Blot analyzing various amounts of rat-tail collagen. As
positive controls commercially available murine GDNF
and protein samples from rat adrenal gland, rat cere-
brum as well as PC12 cells were used. While GDNF
monomers were readily detected in the rat adrenal gland
and rat cerebrum, no GDNF signals were detectable in
any of the collagen dilutions (Figure 5).
Having demonstrated that collagen gels are free of
GDNF, we took advantage of the migration assay and
analyzed GDNF- deficient SCG explants in comparison
to controls. In GDNF KO as well as control SCG
explants a multitude of sympathetic axons were
observed growing from the explanted ganglia visible in
bright field as well as after TH-immunohistochemistry
(Figure 6). This indicates that the overall axonal growth
is not affected by the loss of GDNF in SCG explants.
Unexpectedly however, also many S100 positive cells
were observed associated with the axons in both control
as well as GDNF mutant explants in proximal and
also more distal axonal areas. In addition time-lapse
movies (Additional file 5: Movie S5 and Additional file
6: Movie S6) demonstrae unaltered axonal growth and
normally migrating SC along elongating axons in both
control and GDNF mutant explants. Together, these
data demonstrate that GDNF is not required for SC
migration along sympathetic axons.
GDNF is also dispensable for SC colonization of the
sciatic nerve
Next we addressed in whether GDNF affects SC
colonization of other peripheral nerves. To this end we
examined orthogonal semi-thin sections of GDNF/
TGFb2 double mutant sciatic nerves and controls at
E18.5. Due to perinatal death of the GDNF mutant mice
the analyses are restricted to embryonic stages [18].
It was previously shown that TGFb facilitates GDNF
signaling by recruiting GFRa1 to plasma membranes
[21]. This makes the TGFb2/GDNF double mutant
a good model to study GDNF function. However, no
differences were observed between the control and
the double mutant sciatic nerves (Figure 7 A/B). In
both cases a multitude of SC can be observed in the
orthogonal sectioned nerve (Figure 7 arrowheads). This
Figure 2 PP2, applied at DIV0, prevents axonal SC colonization.
A: Scheme of experimental setup (Expl. = Explantation, Analy. =
Analysis, DIV =Day In Vitro). NGF as well as PP2 were added at DIV0
after SCG explantation. B/C: close up of axons grown from SCG
explants. Scale bars = 100 μm. Numerous SCs populating axons also
in distal regions can be observed in a control explant (B) whereas
only bare axons are visible in a PP2 treated explant (C).
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demonstrates that, at least during embryonic stages, GDNF
is dispensable for SC migration in peripheral nerves.
Discussion
SC are a fundamental component of peripheral nerves
and either solely ensheath or additionally myelinate
axons. By both, SC support the long-term integrity of
axons with the latter also rapid impulse propagation
[22]. SC development, including proliferation, survival,
migration and myelination is regulated by axonal signals
[23]. Many studies have addressed the molecular pro-
cesses that control SC development and disease, however
most of these focused on myelination ([3,24], Svaren and
Meijer, 2008). Less is known about the signals that regu-
late SC colonization of axons following the migration of
SC precursors from the neural crest to nerve trunks [25].
GDNF was previously observed to promote migration of
immortalized SC precursors and primary sciatic nerve
SC [11,16]. SC express GFRa1 the GDNF binding recep-
tor [26,27] in line with the hypothesis that GDNF can
directly signal to SC. To test the role of GDNF for SC
migration along sympathetic axons we used a SC migra-
tion assay, containing elongating axons, the physiological
substrate for SC precursor migration [7], a compound
Figure 3 PP2 rather acts on SC proliferation and survival than on direct SC migration. A: Scheme showing the experimental setup
(Expl. = Explantation, Analy. = Analysis, DIV =Day In Vitro). B/C: Immunohistochemical stainings for TH (green) and pHH3 (red) with DAPI nuclear
counterlabeling of control (B) and PP2 treated (C) SCG explants. Scale bars = 200 μm. Please note the reduced number of pHH3 positive cells
(white arrows) after PP2 treatment in comparison to the control. D/E: close up of ctr (D) and PP2 treated (E) SCs costained with DAPI nuclear
labeling and pHH3. One can appreciate the increased level of fragmented nuclei after PP2 treatment. F: Quantitative analyzes of SC migration
distances in %. (students t test: p value = 0.0508) No significant difference in migration distances was observed when PP2 was added at DIV3.
G: Quantitative analyzes of Proliferation using the pHH3/DAPI ratio in %. A strongly reduced level of mitosis was observed, when PP2 was added
at DIV3 (students t test: p value < 0.0001).
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chemical inhibitor (PP2, [20]) for Src as well as Ret
kinases, signaling cascade components of non-canonical
and canonical GDNF signaling respectively, and SCG
explants of embryonic GDNF KO mice [18] in combin-
ation with time lapse imaging.
Application of PP2 at DIV0 inhibited axonal SC
colonization, so only bare axons were visible during
time-lapse imaging. Further analyzes however, focusing
on SC which were already migrating along growing
axons (DIV3) showed that PP2 only had a mild and
insignificant effect on SC migration distances. How-
ever, PP2 was observed to reduce SC proliferation and
increase SC apoptosis. By blocking SC proliferation (with
Aphidicolin) at DIV0 we were also able to sufficiently
Figure 4 Early inhibition of SC proliferation also prevents axonal SC colonization. A: Scheme showing the experimental setup
(Expl. = Explantation, Aph. = Aphidicolin Analy. = Analysis, DIV =Day In Vitro). B,D,F and H show brightfield images of axonal growth of control
(B and D) and aphidicolin treated samples (F and H). In both conditions axonal growth could be observed. C, E, G and I show DAPI stainings of
controls (C and E) and aphidicolin treated samples (G and I). Where in the control condition a multitude of SC could be observed, in the
aphidicolin treated sample only rarely cells could be observed outside the ganglion (arrows). Nuclear detritus was observed in both conditions
(arrowheads). (Scale bars = 100 μm).
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block axonal SC colonization. We therefore concluded
that PP2, if applied at DIV0, indirectly inhibited axonal
SC colonization, by reducing the number of SC precur-
sors. Though, even if the phenotype induced by PP2 at
DIV0 was caused indirectly it was severe and could
eventually support the hypothesis that GDNF is crucial
for axonal SC colonization. Importantly however, in con-
trast to our expectations, we found no obvious SC
migration phenotype, analyzing SCG explants of GDNF
null embryos in comparison to controls. Accordingly, we
had to conclude that GDNF signaling is neither abso-
lutely required for the proliferation of premigratory SC
nor for their subsequent migration along sympathetic
axons. The absence of obvious defects in SC develop-
ment also indicates that GDNF- mediated axonal release
of heparin-binding forms of NRG1 as observed for cul-
tured DRG neurons [28] is not essential for the develop-
ment of SC in the sympathetic nervous system or is
compensated by the in excess available NGF, which is
also able to release heparin binding forms of NRG1 [28].
The different outcomes of our study and the previous
findings could result from different model systems used,
e.g. that GDNF may serve distinct functions in myelin-
ated and nonmyelinated nerves. However, nonmyelinat-
ing SC have been shown to respond to (exogenously
added) GDNF, which stimulates SC proliferation and
myelination of small caliber axons in adult rats [29].
Finally we wanted to address the in vivo role of GDNF
for SC migration. As GDNF KO mice are not viable
[18], analyzes were restricted to embryonic stages in
which the dissection of postganglionic SCG nerves is
hardly feasible. Therefore we decided to analyze late
embryonic (E18.5) sciatic nerves of GDNF mutants in
comparison to controls. In line with our previous results
in the sympathetic nervous system also in the sciatic
nerve of GDNF (GDNF/ TGFb2) mutants in comparison
to controls no difference with respect to SC populations
could be observed. This indicates that GDNF is dispens-
able for embryonic SC migration in vivo. Even though
endogenous GDNF is dispensable for normal SC devel-
opment it cannot be ruled out that exogenously intro-
duced GDNF is able to affect SC migration, which could
explain previous findings ([16], Corenjo et al., 2010). Al-
ternatively, other GDNF family ligands (such as Neur-
turin) may compensate for the loss of GDNF in SCG
explant cultures and in sciatic nerves in vivo. Normal SC
development in GDNF deficient SCG explants in con-
trast to massively reduced SC proliferation after PP2
application indicates that Src and/ or Ret kinase activities
in SCG explants are regulated by additional extracellular
signals. NRG1 signaling regulates SC proliferation [30,31],
and we have recently shown that NRG1 type III-ErbB sig-
naling promotes SC colonization of distal sympathetic
regions by preventing apoptosis in proximal regions [7].
Since NRG1 signaling also stimulates Src kinase activity
[32,33], it is plausible that Src inactivation by PP2 mimics
to some extend the loss of NRG1 type III ErbB signaling.
Though, it is interesting to note that blocking ErbB recep-
tors leads next to reduced SC proliferation also to
reduced SC colonization of distal axonal compartments
[7], together indicating a more complex ErbB downstream
signaling. Taken together we demonstrate that SC can mi-
grate along sympathetic axons an sciatic nerve axons of
GDNF deficient embryos leading to the conclusion that
GDNF as a factor and also GDNF signaling is dispensable
for SC migration along murine embryonic axons.
Conclusions
In this study we analyzed the role of GDNF for embry-
onic SC migration. In contrast to previous in vitro find-
ings in the sciatic nerve and a SC precursor cell line
[11,16], our data clearly indicate, that GDNF is dispens-
able for embryonic SC migration along sympathetic
axons, demonstrated with the SCG explant SC develop-
ment assay, as well as along the sciatic nerve, demon-
strated with the help of semithin sections of mutant
nerves. Although PP2, a pharmacological inhibitor for
canonical as well as alternative GDNF signaling, showed
a strong effect on axonal SC colonization (applied at
DIV0 to the SCG explant assay), this effect is in fact in-
dependent of GDNF. This is clearly shown, as no pheno-
type could be observed when GDNF mutant SCGs were
used for the SCG explant SC migration assay (Figure 6
and Additional file 5: Movie S5 and Additional file 6:
Movie S6). Further investigations revealed that PP2 acts
Figure 5 The SCG SC development assay is free of GDNF.
Western Blot for GDNF with different dilutions of rat-tail collagen
(20μl, 10μl, 5μl, 2.5μl, 1.25μl and 0.6125μl collagen) were analyzed
using anti-GDNF antibody specific for human and rat GDNF. Rat
adrenal gland (20μg), rat cerebrum (20μg), proteins from
undifferentiated PC12 cells (20μg) and recombinant murine GDNF
(5ng) were used as positive controls. Gapdh was used a loading
control for tissue samples. Whereas recombinant murine GDNF as
well as rat GDNF in samples from adrenal gland and cerebrum were
detectable, no GDNF signal was obtained in the rat-tail collagen of
any amount analyzed.
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rather on SC proliferation and on SC survival than on
SC migration directly (Figure 3). SC motility, was only
affected by trend shown in the quantitative analysis
(Figure 3F) as well as in the Additional file 3: Movie S3/
Additional file 4: Movie S4. These data suggest that SC
proliferation is a prerequisite for the initiation of SC
migration, underlined by the fact that early blockade of
SC proliferaion also prevented axonal SC colonization
A B
Figure 7 GDNF is dispensable for SC migration along the embryonic sciatic nerve. A and B show orthogonal semithin sections of sciatic
nerves of a control (A) and a TGFb2/GDNF double mutant (B). Both nerves show a multitude of SC (arrowheads). (Scale bar = 100 μm).
 
Figure 6 GDNF is dispensable for SC migration along embryonic sympathetic axons. A/B: bright field images taken during time-lapse
imaging (scale bar 100 μm). A: control SCG explant treated with NGF. A multitude of axons are visible and SCs along the axons (arrowheads). B: SCG
explant of GDNF KO. Also many axons are visible, surprisingly also covered by SCs (arrowheads). C-F: Immunohistochemical stainings (scale bar
200 μm), Thyrosine hydroxylase (TH, red) and s100 (green) immunostainings with DAPI nuclear counterstaining. In both control (C/E) as well as in
the GDNF KO explants (D/F) many sympathetic axons labeled by TH can be seen, covered with s100-ir positive labeled SCs. C/D: E18.5, E/F: E15.5.
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(Figure 4). The phenotype induced by PP2, however,
must be the result of an alteration of a different signal-
ing pathway. As Neuregulin1/ErbB signaling can also act
via a src kinase [32,33] and was shown to be involved in
SC proliferation [7,30,31] we conclude that PP2 is inter-
fering with this pathway. Altogether we demonstrated
that SC can migrate along axons in the absence of
GDNF signaling.
Additional files
Additional file 1: Supplemental time-lapse movies (scale bars =
100 μm). Time-lapse movie S1 Ctr SCG Explant (treatment DIV0)
(Imaging started DIV1, frame rate: 30 min).
Additional file 2: Time-lapse movie S2 PP2 treated SCG Explant
(treatment DIV0) (Imaging started DIV1, frame rate: 30 min).
Additional file 3: Time-lapse movie S3 Ctr SCG Explant (treatment
DIV3, Imaging started DIV3, frame rate: 10 min).
Additional file 4: Time-lapse movie S4 PP2 treated SCG Explant
(treatment DIV3, Imaging started DIV3, frame rate: 10 min).
Additional file 5: Time-lapse movie S5 Control SCG Explant
(Imaging started DIV4, frame rate: 30 min).
Additional file 6: Time-lapse movie S6 GDNF mutant SCG Explant
(Imaging started DIV4, frame rate: 30 min).
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